NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 58 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,114,000 | 0.0% | 900,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,114,000 | +47.5% | 900,000 | +50.0% | 0.00% | – |
Q3 2021 | $755,000 | -5.3% | 600,000 | 0.0% | 0.00% | – |
Q2 2021 | $797,000 | -1.2% | 600,000 | 0.0% | 0.00% | – |
Q1 2021 | $807,000 | +94.9% | 600,000 | +100.0% | 0.00% | – |
Q4 2020 | $414,000 | +0.2% | 300,000 | 0.0% | 0.00% | – |
Q3 2020 | $413,000 | -63.0% | 300,000 | -55.4% | 0.00% | -100.0% |
Q2 2020 | $1,117,000 | +86.8% | 672,000 | +43.9% | 0.00% | 0.0% |
Q1 2020 | $598,000 | -16.4% | 467,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $715,000 | -55.6% | 467,000 | -60.3% | 0.00% | 0.0% |
Q3 2019 | $1,609,000 | -26.8% | 1,175,000 | -29.9% | 0.00% | -50.0% |
Q2 2019 | $2,198,000 | +14.5% | 1,675,000 | +18.0% | 0.00% | 0.0% |
Q1 2019 | $1,919,000 | +436.0% | 1,420,000 | +373.3% | 0.00% | – |
Q4 2018 | $358,000 | -73.7% | 300,000 | -62.5% | 0.00% | -100.0% |
Q3 2018 | $1,363,000 | -46.0% | 800,000 | -54.3% | 0.00% | -50.0% |
Q2 2018 | $2,526,000 | – | 1,750,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |